Henry,
I just completed a three-month assignment in Basel, Switzerland working for Novartis. Rumors abound they are in the market for a major acquisition and not a merger. IMO, Novartis is seeking a company with outstanding R&D and I think that Roche doesn't fulfill their needs. Plus there are several strong personalities within both organizations. Even today there is a division between the Sandoz people and the Ciba people. Look for them to pursue companies such as AMGN, BGEN, CHIR (which they already own approx. 49%) and alike.... Sorry AGPH loyal shareholders, I don't think that Novartis would purchase AGPH. The odds on that happening are about the same as people waking-up one day and saying "Hey! those Internet stocks aren't worth all that $$$$$$$$$$$$$"
Richard you wrote "Sort of an embarrassing release, IMO. Someone at CYTL must have needed to sell some stock, but...... that wouldn't be a first for CYTL, eh? ".
Agreed 100%. I still own 20 shares after the last litigation and I'm holding onto them for two reasons:
1) In the event I run out of newspaper when starting my next fire, they would be handy. 2) It's a "PAINFUL" reminder to one who didn't do their homework.
This was posted on the Yahoo! IMNR message board. Can someone confirm?; comments?
remune.com registration details: Registrant: Agouron Pharmaceuticals Inc. (REMUNE-DOM) Information Technology 11095 Torreyana Road San Diego, CA 92121 US
Domain Name: REMUNE.COM
Administrative Contact, Technical Contact, Zone Contact, Billing Contact: Hostmaster (HO1437-ORG) hostmaster@AGOURON.COM +1 619 622-7320 Fax- +1 619 678-8264
Record last updated on 08-Jan-99. Record created on 11-Dec-98. Database last updated on 13-Jan-99 13:52:42 EST.
Best of Luck
Andrew
Disclaimer: I own shares in AMGN/CHIR and wouldn't want to be accused of hyping these stocks. God forbid, I could get kick-off SI and sentenced to life on the Yahoo! message board. Yikes!!!!!!!!!!! |